EFTR insider transaction filings
eFFECTOR Therapeutics, Inc. — 17 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2024-06-13. Screen EFTR transaction legs live →
Insider transaction summary — last 90 days
No Form 4 filings for EFTR between 2026-06-24 and 2026-09-22. The table below lists the most recent filings on record.
Recent Form 4 filings — eFFECTOR Therapeutics, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2024-06-13 | 4 | Harrington-Smith Kristen — Director | Grant/award (A): 800 (derivative) @ $0 | EDGAR |
| 2024-06-13 | 4 | Bhatt Elizabeth — Director | Grant/award (A): 800 (derivative) @ $0 | EDGAR |
| 2024-06-13 | 4 | Gallagher Brian M. Jr. — Director | Grant/award (A): 800 (derivative) @ $0 | EDGAR |
| 2024-06-13 | 4 | Klencke Barbara — Director | Grant/award (A): 800 (derivative) @ $0 | EDGAR |
| 2024-06-13 | 4 | Loewy Caroline M — Director | Grant/award (A): 800 (derivative) @ $0 | EDGAR |
| 2024-06-13 | 4 | Ehrlich Christopher B — Director | Grant/award (A): 800 (derivative) @ $0 | EDGAR |
| 2024-05-17 | 4 | Byrnes Michael — Chief Financial Officer | Grant/award (A): 1,387 @ $1.68 | EDGAR |
| 2024-05-17 | 4 | WORLAND STEPHEN T — Chief Executive Officer, Director | Grant/award (A): 1,806 @ $1.68 | EDGAR |
| 2024-02-21 | 4 | Harrington-Smith Kristen — Director | Grant/award (A): 2,000 (derivative) @ $0 | EDGAR |
| 2024-02-21 | 4 | Warner Douglas J — Chief Medical Officer | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2024-02-21 | 4 | Bhatt Elizabeth — Director | Grant/award (A): 2,000 (derivative) @ $0 | EDGAR |
| 2024-02-21 | 4 | Gallagher Brian M. Jr. — Director | Grant/award (A): 2,000 (derivative) @ $0 | EDGAR |
| 2024-02-21 | 4 | Klencke Barbara — Director | Grant/award (A): 2,000 (derivative) @ $0 | EDGAR |
| 2024-02-21 | 4 | Byrnes Michael — Chief Financial Officer | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2024-02-21 | 4 | Loewy Caroline M — Director | Grant/award (A): 2,000 (derivative) @ $0 | EDGAR |
| 2024-02-21 | 4 | Ehrlich Christopher B — Director | Grant/award (A): 2,000 (derivative) @ $0 | EDGAR |
| 2024-02-21 | 4 | WORLAND STEPHEN T — Chief Executive Officer, Director | Grant/award (A): 80,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — eFFECTOR Therapeutics, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2024-06-26 | 8-K | 2.04 — Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement | EDGAR |
| 2024-06-25 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2024-06-24 | 8-K | ? 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-06-14 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-05-20 | 8-K | 8.01 — Other Events | EDGAR |
| 2024-05-17 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2024-05-09 | 8-K/A | 1.01 — Entry into a Material Definitive Agreement 1.02 — Termination of a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-05-09 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 5.01 — Changes in Control of Registrant | EDGAR |
| 2024-05-09 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-04-04 | 8-K | 8.01 — Other Events | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=EFTR returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →